upadacitinib,linaclotide,risankizumab
Abbvie,ironwood pharmaceutical,Boehringer Ingelheim
['$abbv', 'abbvie']
$abbv new article : abbvie releases new data demonstrating breadth of its gastroenterology portfolio at 2023 digestive disease week 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.